DXB

DIMERIX LTD

• ASX·2h ago

  Dimerix Singapore Investor Briefing

• ASX·03/15 22:22

  Dimerix Presents at Euroz Hartleys Institutional Conference

• ASX·03/15 21:29

  Dimerix to Conduct Review of ACTION3 Statistical Assumptions

• ASX·03/09 22:22

  Dimerix Phase 3 Trial Last Patient Receives First Dose

• ASX·03/03 22:39

  Dimerix Invitation to Perth and Singapore Investor Briefings

• ASX·02/26 22:26

  Dimerix Presents at Oppenheimer Life Sciences Conference

• ASX·02/25 22:32

  Appendix 4D and Half Year Financial Report

• ASX·02/04 22:29

  Dimerix to Present at Euroz Hartleys Healthcare Forum 2026

• Dow Jones·01/30 05:54

  *Dimerix Price Target Cut 1.8% to A$1.65/Share by Euroz Hartleys

• ASX·01/28 22:39

  Quarterly Appendix 4C and Activities Report

• ASX·01/20 21:30

  Appointment of CFO/Company Secretary

• ASX·01/11 21:30

  Clinical trial update at J.P. Morgan Healthcare Conference

• ASX·12/23/2025 21:38

  Dimerix receives input from FDA on ACTION3 trial endpoints

• ASX·12/21/2025 22:18

  BioMarin to acquire Dimerix US Partner, Amicus Therapeutics

• ASX·12/14/2025 21:47

  DMX-200 ACTION3 Phase 3 Trial Completes Recruitment